Alprazolam

Alprazolam dossier: Belgian registration or dossier available for registration in other territories where no BE necessary, reference product Xanax, Patent expired

Offer available for: licensing

Pharmaceutical form and dosage: 0,25-0,5-1,0-2,0 mg Tablets

Type:

- Generics
- Pharmaceuticals / Therapeutics
- Prescription drugs (Rx)

Therapeutic target:

- Central nervous system

Action: Psycholeptics (CNS)

Full Description:
Readily available dossier for licensing
Registration Obtained in Belgium + The Netherlands

Stability: 25°C: 36 months

Availability and Market information:

Status: Registered (MA obtained)

Market(s) and Registration Info: (date: concerns Marketing Authorization)
- Belgium : 1999
- Netherlands
Other: Benelux

Registration info: No BE

Market information

Other Market Info:

Patent Information:
Name: Xanax
Patent info: expired